ArticleThe New England journal of medicine2011
Idiopathic pulmonary fibrosis--a sticky business.
Article in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.Scientific reports · 2021Pooled it
- Pooled it
- Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.Nature genetics · 2013Pooled it
- Article
- Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism.International journal of molecular sciences · 2022Article
- Aberrant Multiciliogenesis in Idiopathic Pulmonary Fibrosis.American journal of respiratory cell and molecular biology · 2022Article
- Clinical characteristics and genetic analysis of a Chinese pedigree of type 2 diabetes complicated with interstitial lung disease.Frontiers in endocrinology · 2022Article
- Identification and immune characteristics of molecular subtypes related to fatty acid metabolism in idiopathic pulmonary fibrosis.Frontiers in nutrition · 2022Article
- Human Fibrosis: Is There Evidence for a Genetic Predisposition in Musculoskeletal Tissues?The Journal of arthroplasty · 2020Review
- Mucins as a New Frontier in Pulmonary Fibrosis.Journal of clinical medicine · 2019Review
- Oxidative stress induces club cell proliferation and pulmonary fibrosis in Atp8b1 mutant mice.Aging · 2019Article
- Regulatory T Cells in Respiratory Health and Diseases.Pulmonary medicine · 2019Review
- The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis consideringBioMed research international · 2019Review
- Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice.Nature communications · 2018Article
- Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.Annals of the American Thoracic Society · 2018Review
- Article
- Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.Physiological reviews · 2016Review
- IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER.Transactions of the American Clinical and Climatological Association · 2016Article
- MUC5B and Idiopathic Pulmonary Fibrosis.Annals of the American Thoracic Society · 2015Article
- Epigenetics in lung fibrosis: from pathobiology to treatment perspective.Current opinion in pulmonary medicine · 2015Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21506745What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.